Embla Medical hf

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: IS0000000040
DKK
37.20
1 (2.76%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Embla Medical hf stock-summary
stock-summary
Embla Medical hf
Pharmaceuticals & Biotechnology
Ossur hf is an Iceland-based company that operates within the field of medical equipment and supplies sector. The Company is active in the development and distribution of products in the fields of non-invasive prosthetics, medical braces and supports. The Company is divided into three market segments: Bracing and Supports, which offers products for therapeutic and preventive purposes; Prosthetics, which offers products for amputees, which include sockets, sleeves, prosthetic knees and feet, as well as supporting components, and Compression Therapy, which offers treatment for venous ulcers and edema. The Company's main markets are North America, Europe and Asia. It has subsidiaries in Iceland, the United States, Canada, Mexico, France, the Netherlands, the United Kingdom, Sweden, Norway, Spain, South Africa, China and Australia.
Company Coordinates stock-summary
Company Details
Grjothals 1-5 , REYKJAVIK None : 110
stock-summary
Tel: 354 5 151300354 515 1380
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Niels Jacobsen
Chairman of the Board
Dr. Kristjan Ragnarsson
Vice Chairman of the Board
Mr. Arne Boye Nielsen
Director
Ms. Gudbjorg Eggertsdottir
Independent Director
Dr. Svafa Gronfeldt
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
1,529 Million
(Quarterly Results - Jun 2025)
Net Profit:
139 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

DKK 15,480 Million ()

stock-summary
P/E

26.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.42

stock-summary
Return on Equity

9.41%

stock-summary
Price to Book

2.81